Form 4: Willis Towers Watson CEO Carl Hess Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Carl Hess, CEO of Willis Towers Watson, reports acquisition and disposal of ordinary shares and restricted share units related to dividend equivalents and deferred savings plans.
Summary
- Carl Hess, the CEO of Willis Towers Watson, filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
- On April 15, 2025, Hess acquired 140.044 ordinary shares at $0, and disposed of 89,427.5787 ordinary shares.
- He also acquired 24.2452 restricted share units related to the Non-Qualified Deferred Savings Plan and 22.5179 restricted share units related to the Non-Qualified Stable Value Excess Plan.
- These restricted share units will settle for ordinary shares on a 1:1 basis, subject to certain conditions related to termination of employment.
Sentiment
Score: 5
Explanation: The document is a neutral regulatory filing, so the sentiment is neither positive nor negative.
Industry Context
This filing is a routine disclosure related to executive compensation and holdings, common in publicly traded companies.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 04/15/2025 | Date of transaction for ordinary shares and restricted share units. |
| 04/17/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Beneficial Ownership, Carl Hess, Willis Towers Watson, WTW, Ordinary Shares, Restricted Share Units, Dividend Equivalent Rights, Non-Qualified Deferred Savings Plan, Non-Qualified Stable Value Excess Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.